You are here
Lessons Learned “Convergence between Pharma and MedTech”
Based on the recent history of the biopharmaceutical industry and its pipeline, can we say it is capable of providing innovative and effective solutions to the most common conditions on its own? The immediate future probably lies in blurring the lines between the development of drugs and medical devices. In this session, companies will share their experience with this convergence of the worlds of biopharmaceuticals and medical devices, a global trend that has already reached our ecosystem in Catalonia.
The sessions Lessons Learned are a knowledge and networking forum geared towards professionals from companies in the life sciences arena. They aim to allow participants to share their experience and reflections in various strategic areas of knowledge and the skills needed to boost competitiveness in biotechnology companies. Between 2014 and 2016, Lessons Learned have attracted more than 600 participants in a total of 15 sessions.
Moderator: Melqui Calzado, General Secretary of CataloniaBio
- Rosendo Garganta, Founder and CEO of Devicare
- Albert Giralt, CEO of Avinent
- Albert Mascarell, CEO of Ascidea
- Eduardo Sales, director of Acura
Registration: € 45 ().
Free for CataloniaBio members and Health Tech Cluster members (send us an e-mail email@example.com to apply discount code)
Language: the session will be in Catalan or Spanish
Time: 4 pm to 7:30 pm
Venue: Barcelona Science Park • Sala Dolors Aleu • Edifici Clústers • C/ Baldiri Reixac, 4-8 • Barcelona
Follow us on Twitter with the hashtag #LessonsLearned